Your browser doesn't support javascript.
loading
A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
Hermanns, Thomas; Savio, Andrea J; Olkhov-Mitsel, Ekaterina; Mari, Andrea; Wettstein, Marian S; Saba, Karim; Bhindi, Bimal; Kuk, Cynthia; Poyet, Cédric; Wild, Peter J; Noon, Aidan; Bashir, Shaheena; Juvet, Tristan; Rendon, Ricardo A; Waltregny, David; van der Kwast, Theodorus; Finelli, Antonio; Kulkarni, Girish S; Fleshner, Neil E; Lo, Kirk; Bapat, Bharati; Zlotta, Alexandre R.
Afiliación
  • Hermanns T; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerla
  • Savio AJ; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
  • Olkhov-Mitsel E; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
  • Mari A; Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
  • Wettstein MS; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
  • Saba K; Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
  • Bhindi B; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Kuk C; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Surgery, Division of Urology, Mount Sinai Hospital, Toronto, Canada.
  • Poyet C; Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
  • Wild PJ; Department of Pathology and Molecular Pathology, University Hospital Zürich, University of Zürich, Zürich, Switzerland; Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt, Germany.
  • Noon A; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Bashir S; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Juvet T; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Rendon RA; Department of Urology, Capital District Health Authority, Halifax, Canada.
  • Waltregny D; Department of Urology, University Hospital of Liège, Liège, Belgium.
  • van der Kwast T; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada; Department of Pathology, University Health Network, Toronto, Canada.
  • Finelli A; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Kulkarni GS; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Fleshner NE; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Lo K; Department of Surgery, Division of Urology, Mount Sinai Hospital, Toronto, Canada.
  • Bapat B; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
  • Zlotta AR; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Surgery, Division of Urology, Mount Sinai Hospital, Toronto, Canada. Electro
Urol Oncol ; 38(6): 603.e1-603.e7, 2020 06.
Article en En | MEDLINE | ID: mdl-32081560
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Biomarcadores de Tumor / Metilación de ADN Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Biomarcadores de Tumor / Metilación de ADN Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2020 Tipo del documento: Article